We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CHKP:NASDAQCheck Point Software Technologies Ltd. Analysis

Data as of 2026-05-23 - not real-time

$133.63

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Check Point (CHKP) is trading at $133.63, comfortably above its 20‑day SMA of $123.09 but still below the 50‑day SMA of $135.48, indicating a mixed short‑term signal. The RSI sits at 57, suggesting neutral momentum, while the MACD histogram is positive (+2.70) and the MACD line has crossed above its signal line, a bullish technical cue. Volatility is high at 75% over the past 30 days, yet the stock’s beta of 0.37 points to lower systematic risk compared with the broader market. Fundamentals remain strong: a PE of 13.7 versus an industry average of 39.5, gross margin of 87.7%, operating margin of 27.7%, and ROE of 38% underscore solid profitability. Cash on hand ($2.77 B) exceeds total debt ($1.97 B), providing ample liquidity, while free cash flow of $730 M supports ongoing buybacks and AI‑security investments. However, the DCF fair value of $119.89 is below the current price, flagging the stock as potentially overvalued with an 8% upside/downside skew. Recent headlines reveal multiple securities‑fraud investigations, adding legal uncertainty to the mix.
Given the strong balance sheet and attractive valuation relative to peers, the medium‑term outlook is positive, especially as the company leans on AI‑driven security solutions and share‑repurchase programs. Nonetheless, the high volatility, bearish longer‑term trend (price below the 200‑day SMA of $173.92), and ongoing litigation counsel caution, suggesting a hold or modest buy for investors comfortable with the risk profile.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • MACD bullish crossover with positive histogram
  • RSI in a neutral zone offering upside potential
  • Strong support at $112.23 well above recent lows

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • PE ratio of 13.7 vs industry average of 39.5 indicates value
  • High operating margins and ROE signal robust profitability
  • Strategic focus on AI security and ongoing share buybacks

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Strong cash generation and low beta reduce market risk
  • Elevated volatility and securities‑fraud investigations add uncertainty
  • Geopolitical exposure in Israel introduces moderate geographic risk

Key Metrics & Analysis

Financial Health

Revenue Growth4.80%
Profit Margin38.37%
P/E Ratio13.7
ROE38.02%
ROA7.79%
Debt/Equity70.12
P/B Ratio5.0
Op. Cash Flow$1.2B
Free Cash Flow$730.3M
Industry P/E39.5

Technical Analysis

TrendBearish
RSI57.3
Support$112.23
Resistance$141.46
MA 20$123.09
MA 50$135.48
MA 200$173.92
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Fair Value$119.89
Target Price$144.32
Upside/Downside8.00%
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.37
Volatility75.11%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.